4EQZ
Crystal structure of human DOT1L in complex with inhibitor FED2
Functional Information from GO Data
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 18 |
| Details | BINDING SITE FOR RESIDUE AW0 A 501 |
| Chain | Residue |
| A | PRO130 |
| A | GLY221 |
| A | ASP222 |
| A | PHE223 |
| A | PHE239 |
| A | VAL240 |
| A | ASN241 |
| A | PHE245 |
| A | TYR312 |
| A | HOH645 |
| A | PHE131 |
| A | ASP161 |
| A | GLY163 |
| A | SER164 |
| A | GLY165 |
| A | VAL169 |
| A | GLU186 |
| A | LYS187 |
Functional Information from SwissProt/UniProt
| site_id | SWS_FT_FI1 |
| Number of Residues | 5 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"12628190","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"1NW3","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI2 |
| Number of Residues | 1 |
| Details | Binding site: {"evidences":[{"source":"PROSITE-ProRule","id":"PRU00902","evidenceCode":"ECO:0000255"},{"source":"PubMed","id":"12628190","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"1NW3","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI3 |
| Number of Residues | 1 |
| Details | Modified residue: {"description":"Phosphoserine","evidences":[{"source":"PubMed","id":"23186163","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |






